Showing results (281-290 of 482) with videos related to

Sort By:
Pageof 49
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Inferring the number of COVID-19 cases from recently reported deathsThibaut Jombart, Kevin van Zandvoort, Timothy W Russell, et al.
Wellcome Open Research|June 11, 2020
Inferring the number of COVID-19 cases from recently reported deathsThibaut Jombart, Kevin van Zandvoort, Timothy W Russell, et al.
British Journal of Cancer|November 11, 2020
The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancerShunfei Yan, Jiachen Xuan, Natalie Brajanovski, et al.
Communications Biology|February 1, 2019
Changes in long-range rDNA-genomic interactions associate with altered RNA polymerase II gene programs during malignant transformationJeannine Diesch, Megan J Bywater, Elaine Sanij, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2018
Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancersMaheshi Udugama, Elaine Sanij, Hsiao P J Voon, et al.
Genome Research|December 3, 2014
A novel role for the Pol I transcription factor UBTF in maintaining genome stability through the regulation of highly transcribed Pol II genesElaine Sanij, Jeannine Diesch, Analia Lesmana, et al.
Cell Death Discovery|September 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancerCarmelo Cerra, Madeleine R C Tancock, Niko Thio, et al.
Blood|January 29, 2021
Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma deathAna Domostegui, Suresh Peddigari, Carol A Mercer, et al.
Blood|February 14, 2013
Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomasJake Shortt, Benjamin P Martin, Andrea Newbold, et al.
Nature Communications|March 29, 2017
Inhibiting the system xC-/glutathione axis selectively targets cancers with mutant-p53 accumulationDavid S Liu, Cuong P Duong, Sue Haupt, et al.
Pageof 49